Stewart DJ, Bosse D, Ocana A, et al. Rethinking Progression-Free Survival (PFS) as a Clinical Trials Surrogate for Overall Survival (OS). 18th World Conference on Lung Cancer (WCLC) 2017, abstract OA 14.02.
Nivolumab plus ipilimumab bij eerder behandeld gemetastaseerd urotheelcarcinoom
okt 2019 | Uro-oncologie